These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27379943)

  • 61. Inhibition of cyclin-dependent kinases 4 and 6 in breast cancer.
    Mayer EL
    Clin Adv Hematol Oncol; 2015 Apr; 13(4):215-7. PubMed ID: 26352578
    [No Abstract]   [Full Text] [Related]  

  • 62. Palbociclib: first global approval.
    Dhillon S
    Drugs; 2015 Apr; 75(5):543-51. PubMed ID: 25792301
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Research progress in advanced melanoma.
    Luo C; Shen J
    Cancer Lett; 2017 Jul; 397():120-126. PubMed ID: 28385603
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting breast cancer with CDK inhibitors.
    Mayer EL
    Curr Oncol Rep; 2015; 17(5):443. PubMed ID: 25716100
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Introduction and commentary: Paving the way for biosimilars in oncology.
    Abraham J
    Semin Oncol; 2013 Dec; 40 Suppl 1():S1-4. PubMed ID: 24267943
    [No Abstract]   [Full Text] [Related]  

  • 66. Reply to letter to the editor 'Primum non nocere' by Templeton and Šeruga.
    Aapro M; Moebus V; Nitz U; O'Shaughnessy J; Pronzato P; Untch M; Tomita D; Bohac C; Leyland-Jones B
    Ann Oncol; 2015 Oct; 26(10):2198-9. PubMed ID: 26153497
    [No Abstract]   [Full Text] [Related]  

  • 67. Cabozantinib approved for first-line treatment of advanced renal cell carcinoma.
    Clin Adv Hematol Oncol; 2018 Feb; 16(2):96. PubMed ID: 29741507
    [No Abstract]   [Full Text] [Related]  

  • 68. Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.
    Havard R; Henry NL
    Future Oncol; 2017 Dec; 13(28):2507-2510. PubMed ID: 29168654
    [No Abstract]   [Full Text] [Related]  

  • 69. The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer.
    Sagara Y; Sato K; Fukuma E; Higaki K; Mizutani M; Osaki A; Takano T; Tokuda Y; Ohno S; Masuda N; Suzuki M; Saeki T
    Jpn J Clin Oncol; 2013 Sep; 43(9):865-73. PubMed ID: 23858037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Current trends in the treatment of primary breast cancer].
    Letiagin VP
    Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
    [No Abstract]   [Full Text] [Related]  

  • 71. The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review.
    Ntanasis-Stathopoulos I; Fotopoulos G; Tzanninis IG; Kotteas EA
    Cancer Invest; 2016 Aug; 34(7):313-39. PubMed ID: 27486869
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adaptive treatments show promise in breast cancer.
    Baker H
    Lancet Oncol; 2016 Aug; 17(8):e327. PubMed ID: 27425815
    [No Abstract]   [Full Text] [Related]  

  • 73. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 75. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
    Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.
    Marquez-Medina D; Popat S
    Future Oncol; 2016 Mar; 12(6):815-25. PubMed ID: 26829230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.
    Radich JP; Mauro MJ
    Hematol Oncol Clin North Am; 2017 Aug; 31(4):577-587. PubMed ID: 28673389
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 37th annual meeting of the American Society of Clinical Oncology. San Francisco, CA, May 12-15, 2001.
    Maung K; D'Orazio AI
    Clin Colorectal Cancer; 2001 Aug; 1(2):76-81. PubMed ID: 12445363
    [No Abstract]   [Full Text] [Related]  

  • 79. [Paclitaxel in therapy of breast carcinoma. Value and perspectives].
    Klaassen U; Seeber S
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():7-10. PubMed ID: 9082172
    [No Abstract]   [Full Text] [Related]  

  • 80. Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II.
    Chen LF; Patel JD; Lukas RV
    Future Oncol; 2016 Dec; 12(23):2669-2672. PubMed ID: 27605123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.